Sildenafil versus Endothelin Receptor Antagonist for Pulmonary Hypertension (SERAPH) Study
Year: 2005
Type: article
Study designs: Randomized Controlled Trial, Clinical Trial
Institutions: Leicester Royal Infirmary, Imperial College London
Language: English
Subfield: Pulmonary and Respiratory Medicine
Field: Medicine
Domain: Health Sciences
Keywords: pulmonary arterial hypertension, sildenafil, bosentan, phosphodiesterase-5 inhibition, endothelin receptor antagonism, right ventricular mass, 6-minute walk distance, brain natriuretic peptide, cardiac function, connective tissue disease-associated pulmonary arterial hypertension, combination therapy, drug safety, sudden death, cardiovascular magnetic resonance
Open Access status: closed
OpenAlex ID: W2121688503
